New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareCagrilintide vs Matrixyl

Cagrilintide vs Matrixyl

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Cagrilintide
Skin & Cosmetic
Matrixyl
Summary
Cagrilintide is a long-acting amylin analog developed by Novo Nordisk. Amylin is a peptide hormone co-secreted with insulin from pancreatic beta cells. Cagrilintide slows gastric emptying, suppresses glucagon, and reduces appetite via central amylin receptors. In combination with semaglutide (CagriSema), Phase 2 trials achieved approximately 15% body weight reduction. Phase 3 trials (REDEFINE program) are ongoing.
Matrixyl is the most widely used collagen-stimulating cosmetic peptide. As a matrikine — a fragment of type I procollagen — it signals skin cells to synthesize new collagen, elastin, and fibronectin, reducing wrinkle depth and improving skin firmness and elasticity.
Half-Life
~7–10 days
N/A — topical; sustained signaling effects on fibroblasts persist beyond single application
Admin Route
SubQ
Topical
Research
Typical Dose
0.16 mg → 0.3 mg → 0.6 mg → 1.2 mg → 2.4 mg
3–8% concentration
Frequency
Once weekly
Once or twice daily
Key Benefits
  • ~15% body weight reduction in combination with semaglutide (CagriSema Phase 2)
  • Synergistic appetite suppression complementing GLP-1 receptor agonists
  • Reduces post-meal glucagon excursions improving glycemic control
  • Slows gastric emptying contributing to prolonged satiety
  • Once-weekly dosing via subcutaneous injection
  • Potential for greater weight loss than semaglutide monotherapy
  • Stimulates collagen I, III, and IV synthesis
  • Increases fibronectin and glycosaminoglycan production
  • Reduces wrinkle depth and length by 27–68% (studies)
  • Improves skin firmness and elasticity
  • Reduces dark circles and undereye bags
  • Synergistic with retinol, vitamin C, and growth factors
  • Suitable for all skin types including sensitive
  • Well-studied with published clinical data
Side Effects
  • Nausea (most common, especially during titration)
  • Vomiting
  • Decreased appetite
  • Diarrhea
  • +2 more
  • Exceptional safety profile
  • Non-irritating, suitable for sensitive skin
  • No known adverse effects at cosmetic concentrations
Stacks With